Stock market news and updates

Nse Index Opens Up 0.04% In Pre Open Trade

Mazagon Dock: Plans To Secure Two New Major Orders In Fy27.

Blue Cloud Softech: Signs $150 Million Deal With Spacex For Ai Infrastructure Over 18 Months

Hero Motocorp: Guidance - The Company Anticipates Positive Growth For The Overall Two-wheeler Industry In H2 Fy27, Despite A Higher Base, With Full-year Industry Growth Approaching Double Digits. - Concall Update

Hero Motocorp: Guidance - Hero Motocorp Expects Fy27 To Be The First Full Year Of Pli Accruals For Its Ev Portfolio, With 60% Currently Certified And 100% Expected To Be Compliant By December 2026, Providing A Strong Structural Tailwind. - Concall Update

Hero Motocorp: Guidance - The Company Plans To Triple Its Ev Capacity Within Fy27, Increasing From 15,000 Units Per Month To 30,000 Per Month By August 2026, And Targeting 45,000 Per Month Before The End Of The Fiscal Year. - Concall Update

Hero Motocorp: Guidance - For Q2 Fy27, Management Expects A Marginal Uptick In Input Cost Inflation, Which They Plan To Neutralize Through Improved Product Mix, Optimized Discretionary Spending, And Accelerated Cost-saving Programs. - Concall Update

Hero Motocorp: Guidance - Management Targets A Medium-term Ebitda Margin Range Of 14% To 16%, Acknowledging That Q1 Fy27's Gross Margin Contracted By 300 Basis Points Due To Commodity Inflation. - Concall Update

Hal: Co Revives Su-30mki Production; ₹60,000-crore Fleet Upgrade Also Planned – Newspaper

Coal Stocks At Power Plants May Fall 20% By September-end On Higher Demand – Newspaper

India’s Non-fossil Power Capacity Has Crossed The 300 Gw Mark, With Solar Energy Emerging As The Key Driver Of Capacity Additions; Milestone Puts The Country At Around 60% Of Its 500 Gw Non-fossil Capacity Target For 2030 – Newspaper

India Weighs Cap On Carbosulfan Use As Government Moves To Restrict Paraquat ( Upl, Insecticides India ) - Newspaper

India May Tighten Control Over Mineral-bearing Land, States Could Need Centre Nod For Levies – Newspaper

India’s Textile Exports Face U.s Setback As Apparel Shipments Fall 18% In First Half Of 2026 - Newspaper

Pg Electroplast: Guidance - For The Full Year, Management Aspires To Achieve An 8% Operating Margin, Excluding Pli And Other Incentives, Noting This Is Not A Formal Guidance.- Concall Update

Suprajit Engineering: Guidance - The Sensors, Electronics, & Displays (sed) Division Is Also Targeted To Achieve An Ebitda Margin Around Last Year's 10%. - Concall Update

Suprajit Engineering: Guidance - India Cables & Mechatronics (icm) And Phoenix Lighting & Electricals (pld) Are Guided To Maintain Margins Around Last Year's Levels, Approximately 5%-15% And 12% Respectively. - Concall Update

Suprajit Engineering: Guidance - Global Cables & Mechatronics (gcm) Is Expected To Achieve Double-digit Growth With An Operational Ebitda Margin Between 10% And 12%. - Concall Update

Suprajit Engineering: Guidance - Consolidated Guidance Projects Double-digit Growth With An Operational Ebitda Margin Range Of 12% To 13.5%. - Concall Update

Suprajit Engineering: Guidance - The Company's Guidance, Issued In A Press Release On May 25, 2026, Remains Unchanged For The Year, With No Concerns About Meeting The Set Targets. - Concall Update

Delhivery: Targets 16% To 18% Ebitda For Express Parcel Services And Aims For The Higher End By H2 Fy27. The Ptl Business Seeks Consistent Margin Growth, Aiming For A Fy27 Ebitda Of Around 15% To 15.5%, With A Long-term Goal Of 16% To 18%.

Delhivery: Express Service Aims For Ebitda Margin Of 16% To 18%, Expecting Higher End In Fy27's Second Half, While Ptl Targets 15% To 15.5% Margin By Year-end. New Initiatives Like Delhivery Direct Show Strong Growth, With Gmv Currently At Nearly Inr 150 Crores, Exceeding Fy27 Goal Of Inr 250 Crores.

Delhivery: Company Expects Growth And Profit Targets To Stay Steady Despite Tough Q1, Aiming For 20% To 30% Volume Growth In Express Business This Year.

Fortis Healthcare: Guidance - The Company Is Actively Evaluating Inorganic Growth Opportunities, Focusing On Existing Clusters, And Has Approved A Inr252 Crore Capex For A Proton Facility At Its Gurgaon Hospital.- Concall Update

Fortis Healthcare: Guidance - Key Levers For Margin Improvement Include New Units (manesar, Noida, Fmri) Transitioning To Positive Ebitda Contribution, Improved Collection From Government And Tpas, And Increased Occupancy In Existing Hospitals Like Bg Road And Mulund.- Concall Update

Fortis Healthcare: Guidance - The Company Plans To Operationalize An Additional 400 Beds In The Remaining Three Quarters Of Fy27, Including 200 Beds From The Fmri Facility, And Anticipates Capex Consuming Approximately 50% Of Ebitda For Brownfield Expansion And Technical Upgrades.- Concall Update

Fortis Healthcare: Guidance - For The Diagnostic Business, Management Expects Revenue Growth Of 12-13% And Ebitda Margins Of 24-25% For The Remaining Quarters Of Fy27, Driven By Continued Momentum And An Improved B2c Mix.- Concall Update

Fortis Healthcare: Guidance - Management Maintains Its Consolidated Ebitda Margin Guidance For Fy27, Expecting To Achieve 25% Ebitda Margin By Fy28, Inclusive Of Esop Costs, Which Will Be Offset By Operational Improvements.- Concall Update

Blue Star: Guidance - The Long-term Operating Margin For The Unitary Products Industry Is Expected To Be 7.5% To 8%, Not 6.5%, Given The 18% Cagr Growth.- Concall Update

Blue Star: Guidance - Management Remains Cautious About The Overall Fy27 Outlook Due To Commodity Price And Exchange Rate Volatility, And The West Asia Conflict, Despite Strong Fundamentals.- Concall Update

Blue Star: Guidance - Capex For Q1 Was Approximately Inr 60-70 Crores, With An Annual Plan For Growth-related Spending Of Inr 300-350 Crores.- Concall Update

Blue Star: Guidance - Commercial Air Conditioning Is Expected To Achieve Around 10% Growth, Though 15% Growth Is Not Yet Predictable.- Concall Update

Blue Star: Guidance - The Company Anticipates Generating An Additional Usd 100 Million Per Annum In Export Revenue From Fy28, Primarily From The Us Market.- Concall Update

Blue Star: Guidance - Data Center Mep Projects Are Projected To Have An Order Inflow Of Inr 3,000 Crores And Revenue Of Inr 1,350 Crores For Fy27, With Fy28 Estimates At Inr 4,500 Crores Order Inflow And Inr 2,100 Crores Revenue.- Concall Update

Blue Star: Guidance - The Margin Outlook For Segment 1 Remains Consistent At 6.5% To 7%. || The Mep Business, Driven By Data Centers, Could See Growth Increase To 12% For A Couple Of Years, Up From The Previously Indicated 8% To 10% Cagr.- Concall Update

Blue Star: Guidance - Management Expects Segment 2 Operating Margin To Be Over 6.5% For Fy27, With An Aspiration Of 7% To 7.5%, Though 7% To 7.5% Is Not Yet A Firm View.- Concall Update

Azad Engineering: Management Confirms Over 25% Long-term Annual Revenue Growth Expectation While Keeping Strong Profitability. Standalone Ebitda Margins Increased To 37.6% In Q1 Fy27, With Management Optimistic About Sustaining This In Future Quarters.

Lupin: U.s. Business Anticipated To Return To Growth Starting Fiscal Year '28, Supported By Strong Pipeline Of Exclusive First-to-files, Biosimilars, And 505(b)(2) Products.

Emcure Pharma: Mosl On Emcure Pharma Maintains Buy With Target Price: ₹2,300 (vs ₹2,260) As Broad-based Growth, Strong Execution, Operating Leverage, And Robust Row, Europe & Canada Performance Offset Subdued India Momentum, Leading To 7%/2% Fy27/fy28 Earnings Upgrades.

Hitachi Energy: Jefferies On Hitachi Energy Maintains Buy With Target Price ₹45,790 As Strong Ebitda Beat, Accelerating Transmission Investments, Healthy Order Inflows, And Data Centre Demand Support A Strong Eps Growth Outlook.

Hitachi Energy: Nomura On Hitachi Energy Initiates Buy With Target Price ₹40,030 As Transmission Capex, Ai-driven Data Centre Demand, Grid Digitalisation, And Hvdc Opportunities Create Strong Structural Growth.

Hitachi Energy: Goldman Sachs On Hitachi Energy Maintains Neutral With Target Price ₹30,100 As Strong Execution And Margins Were Offset By Rich Valuations Despite Healthy Ex-hvdc Order Growth.

Hitachi Energy: Citi On Hitachi Energy Maintains Buy With Target Price ₹46,700 As Strong Order Inflows, Revenue Beat, Stable Margins, And A Healthy Order Book Reinforce Growth Visibility.

Hitachi Energy: Macquarie On Hitachi Energy Maintains Outperform With Target Price ₹38,500 As Strong Execution, Robust Revenue Growth, And Expanding Grid Investments Support Sustained Momentum.

Lupin: Company Confirms Expectations For High Single-digit Revenue Growth And About 25% Ebitda Margins This Year. U.s. Business Forecasted To Be Between $1.1 Billion And $1.2 Billion, With Base Business Growth, Injectable Launches, And Pegfilgrastim Balancing Increased Competition From Products Like Mirabegron And Tolvaptan.

Ge Vernova: Jpmorgan On Ge Vernova Maintains Overweight With Target Price ₹5,200 (cut) As Delayed Us Export Orders And Lower Export Mix Pressure Near-term Growth, But Fy28-29 Order Momentum Remains Attractive.

Kirloskar Oil Engines: Targets $2 Billion Revenue By Fy '30, Aiming For Higher Ebitda Margins And Sustainable Growth.

Ge Vernova: Nomura On Ge Vernova Maintains Buy With Target Price ₹5,675 As Steady Ebitda Performance And Strong Domestic Order Outlook Offset Near-term Tendering Weakness.

Kirloskar Oil Engines: Stays Focused On Ebitda Goals For The Year Despite Global Business Issues, With Expected Profit Rise In Upcoming Quarters Due To Pricing Changes And Cost Management Efforts.

Ge Vernova: Jefferies On Ge Vernova Maintains Hold With Target Price ₹4,850 As Lower Margins Offset Strong Revenue, While Limited Export Visibility Led To Eps Cuts Despite Robust Domestic T&d Demand.

Godrej Consumer Products: Clsa On Gcpl Maintains Underperform With Target Price ₹873 As Raw Material Inflation, Margin Pressure, And Weak Underlying India Demand Temper Growth Optimism.

Godrej Consumer Products: Nomura On Gcpl Maintains Buy With Target Price ₹1,300 As Management Expects Fy27 Performance To Exceed Guidance Despite Weaker Gross Margins.

Godrej Consumer Products: Hsbc On Gcpl Maintains Buy With Target Price ₹1,260 As Resilient International Growth, Particularly Africa, Offset Moderation In India.

Godrej Consumer Products: Jefferies On Gcpl Maintains Buy With Target Price ₹1,400 As Strong Revenue Growth, Market Share Gains, And Confidence In H2 Demand Outweigh Near-term Raw Material Cost Pressures.

Apollo Tyres: Clsa On Apollo Tyres Maintains Outperform With Target Price ₹534 As Sequential Profitability Is Expected To Improve Through Price Hikes Despite Rising Raw Material Inflation.

Apollo Tyres: Nomura On Apollo Tyres Maintains Neutral With Target Price ₹468 As In-line Ebitda, Gradual Benefit Of Price Hikes, Slow Cv Demand, And High Capex Keep Free Cash Flow Subdued.

Sbin: Kotak Institutional Equities On Sbi Maintains Buy With Target Price ₹1,250 As Strong Loan Growth, Recovering Nims, Low Credit Costs, And Resilient Asset Quality Support Premium Valuations.

Sbin: Nomura On Sbi Maintains Neutral With Target Price ₹1,160 As Strong Nim-led Operating Performance And Healthy Loan Growth Were Offset By Lagging Deposit Growth.

Sbin: Jefferies On Sbi Maintains Buy With Target Price ₹1,320 As Higher Nii, Treasury Gains, Strong Asset Quality, And Low Credit Costs Supported Earnings Upgrades.

Sbin: Macquarie On Sbi Maintains Outperform With Target Price ₹1,150 As Resilient Margins, Disciplined Costs, And Robust Loan Growth Drove Earnings Above Estimates Despite Weaker Non-interest Income.

Sbin: Jpmorgan On Sbi Maintains Overweight With Target Price ₹1,290 As Broad-based Earnings Beat, Strong Loan Growth, Improved Guidance, And Resilient Asset Quality Strengthened Confidence.

Sbin: Morgan Stanley On Sbi Maintains Equal-weight With Target Price ₹1,070 As Stronger-than-expected Nims Improved Forecasts, Though Valuations Remain Full.

Sbin: Hsbc On Sbi Maintains Buy With Target Price ₹1,310 As Strong Nims, Fee Income, Cost Control, And Low Credit Costs Delivered An All-round Earnings Beat.

Sbin: Citi On Sbi Maintains Buy With Target Price ₹1,300 As Nim Recovery, Strong Earnings Beat, Healthy Loan Growth, And Stable Asset Quality Reinforced Fy27 Guidance.

Sbin: Bernstein On Sbi Maintains Market Perform With Target Price ₹1,300 As Steady Loan Growth, Improving Nims, Strong Fee Income, And Stable Asset Quality Supported A Solid Quarter Despite Subdued Deposits.

Sbin: Clsa On Sbi Maintains Outperform With Target Price ₹1,325 (raised) As Broad-based Loan Growth, Nim Expansion, Robust Asset Quality, And Earnings Beat Drove Pat Estimate Upgrades.

Titan: Jpmorgan On Titan Maintains Overweight With Target Price ₹5,465 As Strong Q1 Execution, Robust Jewellery Demand, And Resilient Margins Led To Earnings Upgrades Despite Customs Duty Changes.

Titan: Citi On Titan Maintains Buy With Target Price ₹5,700 (raised) As Strong Jewellery Revenue, Healthy Profitability, And Favourable Product Mix Support 5-10% Fy27-29 Eps Upgrades.

Titan: Hsbc On Titan Maintains Buy With Target Price ₹5,550 As Resilient Jewellery Margins And Robust Growth Outlook Drove Eps Upgrades Despite Slight July Moderation.

Titan: Jefferies On Titan Maintains Hold With Target Price ₹5,000 As Strong Jewellery Growth And Stable Underlying Margins Support Higher Earnings Estimates Despite Gold Price Volatility.

Ramco Cements: Kotak Institutional Equities On Ramco Cements Maintains Sell With Target Price ₹730 As Ebitda Missed On Weak Margins, While Cautious Capex And Regional Headwinds Keep Earnings Outlook Volatile.

Ramco Cements: Clsa On Ramco Cements Maintains Underperform With Target Price ₹755 As Healthy Volume Growth Was Offset By Weak Profitability, With Margin Recovery Dependent On Easing Input Costs Despite Ongoing Expansion.

Ramco Cements: Jefferies On Ramco Cements Maintains Hold With Target Price ₹900 As Weak Pricing And Higher Costs Hurt Ebitda Despite Improving Volumes, With South India Cost Pressures Likely To Keep Profitability Subdued.

Delhivery: Morgan Stanley On Delhivery Maintains Equal-weight With Target Price ₹500 As Strong Revenue Growth Was Offset By Margin Pressure From Higher Costs, Although Management Upgraded Fy27 Volume Outlook And Expects Margin Recovery.

Delhivery: Jpmorgan On Delhivery Maintains Overweight With Target Price ₹590 (cut) As Inflation-led Earnings Miss Impacted Margins, But Strong Parcel Growth Guidance And Expectations Of Sharp H2 Margin Recovery Support The Long-term Outlook.

Delhivery: Jefferies On Delhivery Maintains Buy With Target Price ₹540 As Near-term Margin Pressure From Wage And Fuel Inflation Overshadowed Ebitda Miss, While Strong Volume Growth, Ptl Execution, And Industry Tailwinds Support Recovery In H2fy27.

Kaynes: Kotak Institutional Equities On Kaynes Maintains Reduce With Target Price ₹3,550 As Strong Core Operations Were Offset By Higher Interest And Depreciation Costs, Negative Operating Cash Flow, And Pat Estimate Cuts Despite Upcoming Osat And Pcb Contributions.

Kaynes: Nomura On Kaynes Maintains Neutral With Target Price ₹4,094 As Ebitda Beat Estimates And Ems Growth Outlook Remains Strong, But Elevated Working Capital, Weaker Cash Flows, And Eps Cuts Due To Higher Depreciation And Tax Rates Temper Optimism.

Kaynes: Jpmorgan On Kaynes Maintains Neutral With Target Price ₹3,600 As Revenue And Margin Beat Expectations On Strong Ems Growth, But Rising Working Capital Days, Weak Smart Meter Collections, And 7-9% Eps Cuts Remain Overhangs.

Kaynes: Clsa On Kaynes Maintains Hold With Target Price ₹3,650 (raised) As Strong Q1 Operational Performance Beat Estimates, But Elevated Working Capital, Negative Operating Cash Flow, And Weaker Balance Sheet Metrics Remain Key Concerns Despite Osat/pcb Growth Visibility.

Pfc: Clsa On Pfc Maintains Op With Target Price Cut To ₹500 As 1q Loan Growth Stood At 4% Yoy Despite Rbpf Run-down, Core Margins Softened Qoq, Asset Quality Remained Benign, And Merger Completion Remains Targeted For April 2027; Fy27 Pat Estimate Cut 2%-3%.

Rec: Clsa On Rec Maintains Op With Target Price Cut To ₹420 As 1q Loan Growth Slowed To 1% Yoy Due To Rbpf Run-down, Core Margins Moderated, And Sharp Fx Loss From Rupee Depreciation, While Asset Quality Remained Benign; Fy27 Pat Estimate Cut 2%-3%.

Godrej Consumer: Launches Godrej Rizz Liquid Dishwash In A Growing Inr 2,500-3,000 Crore Market.

Godrej Consumer: Expects Good Performance Despite Cash Constraints, Volume Growth In India Projected At 8% For The Year

Godrej Consumer: Company Confident About Meeting Full-year Goals, Aiming To Surpass Revenue Growth And Possibly Exceed Ebitda And Volume Targets Depending On Commodity Trends.

Jyoti Cnc: Is Working On Bigger Machines, Introducing 8-meter And 10-meter Models After The 6-meter One. The Company Is Also Creating Its Own Drives, Motors, And Cnc Controllers, With The Human-machine Interface Ready, And Plans To Commercialize Within Two Years.

Jyoti Cnc: Anticipates Robust Performance In The Second Half Of Fy27 Due To Strong Demand And New Capacity, With Operating Cash Flow Estimated At 50% Of Ebitda. The Company Introduced A New High-precision Double-column Machine, Nx, Aimed At The Railway Sector, Commercial Vehicles, Infrastructure, Power, And Heavy Engineering, Which Were Mostly Imported Before.

Jyoti Cnc: Expects Capital Expenditure For Fy27 To Range From Inr200 Crore To Inr250 Crore, With A New 10,000 Machine Capacity Facility Starting Operations By The End Of September. Total Machine Sales For Fy27 Are Anticipated To Surpass 8,000 Units, And The Yearly Order Book Should Be Between Inr2,500 Crore And Inr3,000 Crore.

Jyoti Cnc: Expects Revenue Growth Of 25% To 30% For Fy27, While Maintaining Ebitda Margins Around 25%. Huron Forecasts Fy27 Revenue Between Inr300 Crore And Inr325 Crore, With Ebitda Margins Of 8% To 10%, And Positive Pat.

Healthcare Global Enterprises: Guidance - Annual Maintenance Capex Is Targeted At Approximately Inr 100 Crores, And The Marketing Spend Is Expected To Be In The 2.5-2.6% Range Of Sales Long-term.- Concall Update

Healthcare Global Enterprises: Guidance - Planned Bed Expansion Includes 65 Beds In Fy27, 520 Beds In Fy28-fy29, And 230 Beds In Fy30, With Approximately 60% From Brownfield Projects For Faster Execution And Lower Capex.- Concall Update

Healthcare Global Enterprises: Guidance - The North Bangalore Hospital Is Expected To Achieve Monthly Break-even This Year, With Optimal Utilization Of 60-65% Within Three To Four Years Of Operation, And Its Losses Are Projected To Decrease From The Q1 Peak.- Concall Update

Healthcare Global Enterprises: Guidance - The Company Targets Ebitda Margins Of 21-22% In The Next Two Years And 25% Within The Next Four To Five Years, Driven By Improved Payor Mix, Investment In Clinical Technology, And Better Operating Leverage From Maturing Centers.- Concall Update

Healthcare Global Enterprises: Guidance - Management Maintains A Mid-teens Revenue Growth Outlook From Existing And New Centers, With A Focus On Margin Improvement Driven By Payor Mix, Clinical Complexity, Reduced Losses From New Hospitals, And Operating Leverage.- Concall Update

Electronics Mart India: Guidance - All Planned Capex Will Be Funded Through Internal Accruals, With No Inorganic Or Rapid Expansion, Maintaining A Calculated Pace.- Concall Update

Electronics Mart India: Guidance - Total Capex For Upcoming Stores Is Estimated At Around Inr100 Crores, Plus An Additional Inr50 Crores For Property Acquisition In Kolkata Over The Next Two Years.- Concall Update

Electronics Mart India: Guidance - For The Ncr Market, 8 To 10 New Stores Are Planned For Fy '27, With A Long-term Focus On Expansion.- Concall Update

Electronics Mart India: Guidance - The Company Plans To Open 25-30 New Stores Across Existing Geographies And West Bengal, With 5 Stores In Kolkata Operational By Diwali And 10-12 By Q4 Fy '27.- Concall Update

Electronics Mart India: Guidance - Interest Costs For Fy '27 Are Anticipated To Be Less By At Least Inr10 Crores Compared To The Previous Year.- Concall Update

Electronics Mart India: Guidance - Post-ind As Ebitda Margins For The Full Year Are Expected To Be Between 7.5% And 8%, With 9% Considered Too Optimistic.- Concall Update

Electronics Mart India: Guidance - The Full-year Gross Margin Is Projected To Be Above 15%, Specifically Between 15% And 15.5%.- Concall Update

Electronics Mart India: Guidance - For Fy '27, Management Targets A Revenue Growth Of 18% To 20%, With The Festive Period In Q3 Expected To Be Strong.- Concall Update

Apollo Tyres: Plans To Boost Capacity By Adding Hungary To Increase Daily Output From 17,000 To 21,000 Car Tires, Production Set To Start In H2, While India's Capacity Expected To Launch By End Of Fy27 And Increase Through Fy28.

Apollo Tyres: Reports Slow Revenue Growth In Q1 Fy27, But Sees Strong Demand For July; Expects Raw Material Costs To Rise By 8% In Q2 And Benefits From Plant Restructuring In H2.

Apollo Micro: Expects Consolidated Order Book To Hit Inr 3,500 To Inr 4,000 Crores By Year-end Due To New Large Orders. Apollo And Premier Will Continue Operating Separately For Now, With Plans For Future Integration To Be Revealed Within The Next Two To Three Months After The Acquisition Is Finalized.

Apollo Micro: Expects Ongoing Growth But Excludes Export Prospects From Revenue Outlook.

Apollo Micro: Confirms Revenue Growth Guidance Of 40% To 45% For Fy27, Both Consolidated And Standalone. New Guidance For Fy28 Will Be Provided At Fy27's End.

M&m: Mahindra Group Names Shveta Arya As Group Chief Strategy Officer After Serving As Md Of Cummins India.

Gland Pharma: Co. Forms Key Cdmo Partnership With Major Global Pharma For Sterile Injectable Production

Bajel Projects: Co. Wins Major Contract For Epc Transmission Line Construction Worth Rs. 300-400 Crore

Arss Infra: Company Secures Contract Valued At ₹19 Crores

Earnings Today: Abans Financial Services, Amara Raja Energy & Mobility, Asian Hotels (north), Astra Microwave Products, Astrazeneca Pharma India, Antony Waste Handling Cell, Bajaj Steel Industries, Bharat Forge, Bombay Dyeing & Manufacturing Co, Bosch, Carysil, Choice International, Cmr Green Technologies, Cms Info Systems, Dilip Buildcon, Ddev Plastiks Industries, Dmcc Speciality Chemicals, Dollar Industries, Dhunseri Ventures, Eco Recycling, Embassy Developments, Euro Pratik Sales, Exicom Tele-systems, Fusion Finance, Garuda Construction And Engineering, Gfl, Ghv Infra Projects, Gland Pharma, Glottis, Hindustan Copper, Hle Glascoat, Hpl Electric & Power, Vodafone Idea, Ideaforge Technology, Indo Borax & Chemicals, Ind-swift Lab, Iol Chemicals & Pharma, India Tourism Development Corp, Jain Irrigation Systems, Jubilant Pharmova, Kec International, Kolte-patil Developers, Kwality Pharma, K.p.r. Mill, Ksh International, Laser Power & Infra, Linde India, Lloyds Metals And Energy, Lumax Auto Technologies, Manaksia Steels, M & B Engineering, Modern Insulators, Monarch Networth Capital, Manoj Vaibhav Gems N Jewellers, Info Edge (india), Ndr Auto Components, Nintec Systems, Nirlon, Patel Engineering, Pc Jeweller, Pitti Engineering, Platinum Industries, Precision Wires India, Advit Jewels, Ramco Industries, Ramky Infra, Redtape, Midwest Energy, Rir Power Electronics, Rrp Defense, Rupa & Co, S Chand And Co, Sharda Motor Industries, Sharat Industries, Sk Minerals & Additives, Sparc, Speciality Restaurants, Talbros Automotive Components, Tarsons Products, Tgv Sraac, Triveni Turbine, Tvs Supply Chain Solutions, United Polyfab Gujarat, Uttam Sugar Mills, Veedol Corp, Venus Pipes & Tubes, Websol Energy System, Windlas Biotech, Wockhardt, Yatharth Hospital & Trauma Care Services, Zeel

India 10 Year Benchmark Govt Bond Yield At 6.7735% Vs 6.7651% Previous Close

India Rupee Opens At 95.17 Against Dollar Vs 95.2075 Previous Close

Oswal Pumps: Q1 Cons Net Profit 538m Rupees Vs 947m (yoy) || Q1 Revenue 4.73 Rupees Vs 5.14b (yoy)

Oswal Pumps: Q1 Ebitda 744m Rupees Vs 1.4b (yoy) || Q1 Ebitda Margin 15.71% Vs 27.39% (yoy)

Studds Accessories: Q1 Ebitda 202m Rupees Vs 304m (yoy) || Q1 Ebitda Margin 12.08% Vs 20.53% (yoy)

Studds Accessories: Q1 Sl Net Profit 132m Rupees Vs 205m (yoy) || Q1 Revenue 1.67b Rupees Vs 1.48b (yoy)